{
    "code": "06015194",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06015194",
    "time": "2020-11-06 03:37:57",
    "許可證字號": "衛署醫器輸字第015194號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4354",
    "有效日期": "114\/12\/02",
    "發證日期": "94\/12\/02",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00601519404",
    "中文品名": "英尤凱總量IgE檢測試劑",
    "英文品名": "Immuno CAP Total IgE",
    "效能": "用於體外測試人類血清或血漿檢體中循環系統IgE的定量方法。",
    "醫器規格": "詳如附冊。\r\n增加規格   產品:Total IgE Conjugate 400；處方:β-galactosidase-anti-IgE(mouse monoclonal antibodies)approximately 2ug\/ml;Sodium Azide 0.06%；規格20.5ml;6vials。\r\n註銷產品（含處方、規格）：IgE FEIA Reagents、IgE FEIA Standard、Pharmacia Total IgE control LMH、Anti-IgE ImmunoCAP FEIA Carrier。\r\n規格變更為：詳如中文仿單核定本（原94年12月19日及98年2月17日核定之仿單標籤核定本予以作廢）。\r\n註銷規格：ImmunoCAP Total IgE (10-9251-41)、Quality Club Total IgE (10-9297-41)。規格及標籤仿單變更為：詳如中文仿單核定本（原103年5月23日仿單標籤核定本正本收回作廢）。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C5510免疫球蛋白A，G，M，D及E免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620110P095  台灣法迪亞股份有限公司",
    "申請商地址": "台北市內湖區洲子街85號6樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "MSE0039100  PHADIA AB",
            "製造廠廠址": "RAPSGATAN 7P, P.O. BOX 6460, 751 37 UPPSALA, SWEDEN",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060151940002-106-04-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06015194&Seq=002&Type=9"
        },
        {
            "title": "060151940002-106-04-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06015194&Seq=002&Type=8"
        }
    ]
}